🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Obesity is one of the characteristics of type 2 diabetes mellitus. Most of ...
Status
Unknown
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02503943
Treatments Being Tested
This study is for people who have multiple sclerosis, acute leukemia (in re...
Status
Suspended
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2024-01-26
Trial ID
NCT06171152
Treatments Being Tested
Liraglutide is a glucose-like peptide 1 agonist, currently used as an effec...
Status
Unknown
Location
Multiple Locations
Start Date
2020-04-01
Trial ID
NCT04008290
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability of ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-06
Trial ID
NCT01870297
Treatments Being Tested
This trial is conducted in Europe. The aim of this trial is to test for bio...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2004-05-28
Trial ID
NCT01508897
Treatments Being Tested
The objective of the trial is to study whether daily treatment with liraglu...
Status
Completed
Location
University of Oulu and Oulu University Hospital, Dept of Children and Adolescents
Start Date
2016-03
Trial ID
NCT02898506
The goal of this clinical trial is to evaluate the effect of adding a digi-...
Status
Recruiting
Location
HKH Crown Princess Victoria's Childrens and youth Hospital Linköping
Start Date
2026-02-13
Trial ID
NCT06836284
Treatments Being Tested
Basal-bolus insulin therapy is recommended for patients with poorly control...
Status
Completed
Location
Grady Health System
Start Date
2019-01-15
Trial ID
NCT03737240
Treatments Being Tested
The purpose of this study is to investigate transfer of liraglutide from bl...
Status
Completed
Location
Diabetes Research Division, Department of Medicine
Start Date
2012-01
Trial ID
NCT02104037
Treatments Being Tested
Liraglutide is a glucagon like peptide -1 (GLP-1) agonist, which is approve...
Status
Terminated
Location
Vancouver General Hospital - Diamond Center
Start Date
2012-02
Trial ID
NCT01542242
Treatments Being Tested